Please contact our sales team for your Consulting and Customization queries/concerns at [email protected].
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
Highlights
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was valued at US$ 174 million in 2022 and is anticipated to reach US$ 316.2 million by 2029, witnessing a CAGR of 8.8% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICAD (Intracranial Atherosclerotic Disease) Pathology.
The ICAD (Intracranial Atherosclerotic Disease) Pathology market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global ICAD (Intracranial Atherosclerotic Disease) Pathology market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- Stryker
- Balt
- TERUMO
- MicroPort
- Acandis
Segment by Type
- Stent
- PTA Balloon
Segment by Application
- Hospital
- Clinic
- Other
Consumption by Region
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Table of Contents
1 Sutures Needle Market Overview
1.1 Product Overview and Scope of Sutures Needle
1.2 Sutures Needle Segment by Type
1.2.1 Global Sutures Needle Market Value Comparison by Type (2023-2029)
1.2.2 Corner Needle
1.2.3 Shovel Needle
1.2.4 Straight Needle
1.2.5 Round Needle
1.2.6 Other
1.3 Sutures Needle Segment by Application
1.3.1 Global Sutures Needle Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ASCs
1.4 Global Sutures Needle Market Size Estimates and Forecasts
1.4.1 Global Sutures Needle Revenue 2018-2029
1.4.2 Global Sutures Needle Sales 2018-2029
1.4.3 Global Sutures Needle Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sutures Needle Market Competition by Manufacturers
2.1 Global Sutures Needle Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sutures Needle Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sutures Needle Average Price by Manufacturers (2018-2023)
2.4 Global Sutures Needle Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sutures Needle, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sutures Needle, Product Type & Application
2.7 Sutures Needle Market Competitive Situation and Trends
2.7.1 Sutures Needle Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sutures Needle Players Market Share by Revenue
2.7.3 Global Sutures Needle Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sutures Needle Retrospective Market Scenario by Region
3.1 Global Sutures Needle Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sutures Needle Global Sutures Needle Sales by Region: 2018-2029
3.2.1 Global Sutures Needle Sales by Region: 2018-2023
3.2.2 Global Sutures Needle Sales by Region: 2024-2029
3.3 Global Sutures Needle Global Sutures Needle Revenue by Region: 2018-2029
3.3.1 Global Sutures Needle Revenue by Region: 2018-2023
3.3.2 Global Sutures Needle Revenue by Region: 2024-2029
3.4 North America Sutures Needle Market Facts & Figures by Country
3.4.1 North America Sutures Needle Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sutures Needle Sales by Country (2018-2029)
3.4.3 North America Sutures Needle Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sutures Needle Market Facts & Figures by Country
3.5.1 Europe Sutures Needle Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sutures Needle Sales by Country (2018-2029)
3.5.3 Europe Sutures Needle Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sutures Needle Market Facts & Figures by Country
3.6.1 Asia Pacific Sutures Needle Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sutures Needle Sales by Country (2018-2029)
3.6.3 Asia Pacific Sutures Needle Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sutures Needle Market Facts & Figures by Country
3.7.1 Latin America Sutures Needle Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sutures Needle Sales by Country (2018-2029)
3.7.3 Latin America Sutures Needle Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sutures Needle Market Facts & Figures by Country
3.8.1 Middle East and Africa Sutures Needle Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sutures Needle Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sutures Needle Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sutures Needle Sales by Type (2018-2029)
4.1.1 Global Sutures Needle Sales by Type (2018-2023)
4.1.2 Global Sutures Needle Sales by Type (2024-2029)
4.1.3 Global Sutures Needle Sales Market Share by Type (2018-2029)
4.2 Global Sutures Needle Revenue by Type (2018-2029)
4.2.1 Global Sutures Needle Revenue by Type (2018-2023)
4.2.2 Global Sutures Needle Revenue by Type (2024-2029)
4.2.3 Global Sutures Needle Revenue Market Share by Type (2018-2029)
4.3 Global Sutures Needle Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sutures Needle Sales by Application (2018-2029)
5.1.1 Global Sutures Needle Sales by Application (2018-2023)
5.1.2 Global Sutures Needle Sales by Application (2024-2029)
5.1.3 Global Sutures Needle Sales Market Share by Application (2018-2029)
5.2 Global Sutures Needle Revenue by Application (2018-2029)
5.2.1 Global Sutures Needle Revenue by Application (2018-2023)
5.2.2 Global Sutures Needle Revenue by Application (2024-2029)
5.2.3 Global Sutures Needle Revenue Market Share by Application (2018-2029)
5.3 Global Sutures Needle Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Johnson & Johnson Sutures Needle Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Medtronic Sutures Needle Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 B.Braun
6.3.1 B.Braun Corporation Information
6.3.2 B.Braun Description and Business Overview
6.3.3 B.Braun Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.3.4 B.Braun Sutures Needle Product Portfolio
6.3.5 B.Braun Recent Developments/Updates
6.4 Teleflex
6.4.1 Teleflex Corporation Information
6.4.2 Teleflex Description and Business Overview
6.4.3 Teleflex Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teleflex Sutures Needle Product Portfolio
6.4.5 Teleflex Recent Developments/Updates
6.5 Hu-Friedy
6.5.1 Hu-Friedy Corporation Information
6.5.2 Hu-Friedy Description and Business Overview
6.5.3 Hu-Friedy Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hu-Friedy Sutures Needle Product Portfolio
6.5.5 Hu-Friedy Recent Developments/Updates
6.6 Peters Surgical
6.6.1 Peters Surgical Corporation Information
6.6.2 Peters Surgical Description and Business Overview
6.6.3 Peters Surgical Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Peters Surgical Sutures Needle Product Portfolio
6.6.5 Peters Surgical Recent Developments/Updates
6.7 Shanghai Jinhuan
6.6.1 Shanghai Jinhuan Corporation Information
6.6.2 Shanghai Jinhuan Description and Business Overview
6.6.3 Shanghai Jinhuan Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai Jinhuan Sutures Needle Product Portfolio
6.7.5 Shanghai Jinhuan Recent Developments/Updates
6.8 Aurolab
6.8.1 Aurolab Corporation Information
6.8.2 Aurolab Description and Business Overview
6.8.3 Aurolab Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Aurolab Sutures Needle Product Portfolio
6.8.5 Aurolab Recent Developments/Updates
6.9 WEIHAI WEGO
6.9.1 WEIHAI WEGO Corporation Information
6.9.2 WEIHAI WEGO Description and Business Overview
6.9.3 WEIHAI WEGO Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.9.4 WEIHAI WEGO Sutures Needle Product Portfolio
6.9.5 WEIHAI WEGO Recent Developments/Updates
6.10 FSSB
6.10.1 FSSB Corporation Information
6.10.2 FSSB Description and Business Overview
6.10.3 FSSB Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.10.4 FSSB Sutures Needle Product Portfolio
6.10.5 FSSB Recent Developments/Updates
6.11 Kono Seisakusho
6.11.1 Kono Seisakusho Corporation Information
6.11.2 Kono Seisakusho Sutures Needle Description and Business Overview
6.11.3 Kono Seisakusho Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Kono Seisakusho Sutures Needle Product Portfolio
6.11.5 Kono Seisakusho Recent Developments/Updates
6.12 DemeTech
6.12.1 DemeTech Corporation Information
6.12.2 DemeTech Sutures Needle Description and Business Overview
6.12.3 DemeTech Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.12.4 DemeTech Sutures Needle Product Portfolio
6.12.5 DemeTech Recent Developments/Updates
6.13 Dolphin (Futura Surgicare)
6.13.1 Dolphin (Futura Surgicare) Corporation Information
6.13.2 Dolphin (Futura Surgicare) Sutures Needle Description and Business Overview
6.13.3 Dolphin (Futura Surgicare) Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Dolphin (Futura Surgicare) Sutures Needle Product Portfolio
6.13.5 Dolphin (Futura Surgicare) Recent Developments/Updates
6.14 Gore Medical
6.14.1 Gore Medical Corporation Information
6.14.2 Gore Medical Sutures Needle Description and Business Overview
6.14.3 Gore Medical Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Gore Medical Sutures Needle Product Portfolio
6.14.5 Gore Medical Recent Developments/Updates
6.15 Unik Surgical Sutures MFG
6.15.1 Unik Surgical Sutures MFG Corporation Information
6.15.2 Unik Surgical Sutures MFG Sutures Needle Description and Business Overview
6.15.3 Unik Surgical Sutures MFG Sutures Needle Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Unik Surgical Sutures MFG Sutures Needle Product Portfolio
6.15.5 Unik Surgical Sutures MFG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sutures Needle Industry Chain Analysis
7.2 Sutures Needle Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sutures Needle Production Mode & Process
7.4 Sutures Needle Sales and Marketing
7.4.1 Sutures Needle Sales Channels
7.4.2 Sutures Needle Distributors
7.5 Sutures Needle Customers
8 Sutures Needle Market Dynamics
8.1 Sutures Needle Industry Trends
8.2 Sutures Needle Market Drivers
8.3 Sutures Needle Market Challenges
8.4 Sutures Needle Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitive Situation by Manufacturers in 2022
Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers (2018-2023)
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Product Type & Application
Table 12. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2018-2023) & (Units)
Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2018-2023)
Table 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2024-2029) & (Units)
Table 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2024-2029)
Table 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2018-2023)
Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2024-2029)
Table 25. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
Table 27. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (Units)
Table 28. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
Table 32. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (Units)
Table 33. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
Table 42. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (Units)
Table 43. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Type (2018-2023)
Table 51. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Type (2024-2029)
Table 52. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2018-2023)
Table 53. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2024-2029)
Table 54. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) by Type (2018-2023)
Table 55. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) by Type (2024-2029)
Table 56. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2018-2023)
Table 57. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2024-2029)
Table 58. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Type (2018-2023)
Table 59. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Type (2024-2029)
Table 60. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Application (2018-2023)
Table 61. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Application (2024-2029)
Table 62. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2018-2023)
Table 63. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2024-2029)
Table 64. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) by Application (2018-2023)
Table 65. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) by Application (2024-2029)
Table 66. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2018-2023)
Table 67. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2024-2029)
Table 68. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Application (2018-2023)
Table 69. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Application (2024-2029)
Table 70. Stryker Corporation Information
Table 71. Stryker Description and Business Overview
Table 72. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 74. Stryker Recent Developments/Updates
Table 75. Balt Corporation Information
Table 76. Balt Description and Business Overview
Table 77. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 79. Balt Recent Developments/Updates
Table 80. TERUMO Corporation Information
Table 81. TERUMO Description and Business Overview
Table 82. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 84. TERUMO Recent Developments/Updates
Table 85. MicroPort Corporation Information
Table 86. MicroPort Description and Business Overview
Table 87. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 89. MicroPort Recent Developments/Updates
Table 90. Acandis Corporation Information
Table 91. Acandis Description and Business Overview
Table 92. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 94. Acandis Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
Table 98. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List
Table 99. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends
Table 100. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
Table 101. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
Table 102. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type in 2022 & 2029
Figure 4. Stent Product Picture
Figure 5. PTA Balloon Product Picture
Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2018-2029) & (US$ Million)
Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2018-2029) & (Units)
Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price (USD/Unit) & (2018-2029)
Figure 15. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
Figure 16. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Manufacturers in 2022
Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest ICAD (Intracranial Atherosclerotic Disease) Pathology Players: Market Share by Revenue in 2022
Figure 19. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2018-2029)
Figure 22. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2018-2029)
Figure 23. U.S. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2018-2029)
Figure 26. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2018-2029)
Figure 27. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2018-2029)
Figure 34. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2018-2029)
Figure 45. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2018-2029)
Figure 46. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2018-2029)
Figure 51. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Type (2018-2029)
Figure 55. Global Revenue Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Type (2018-2029)
Figure 56. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application (2018-2029)
Figure 58. Global Revenue Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application (2018-2029)
Figure 59. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Application (2018-2029)
Figure 60. ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain
Figure 61. ICAD (Intracranial Atherosclerotic Disease) Pathology Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
|
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2022 - Market Size, Current Insights and Development Trends
Intracranial atherosclerotic disease (ICAD) is the most common cause of stroke worldwide. It is the progressive narrowing of the cerebral arteries within the skull (intracranial). Strokes may be caused either by clots or by bleeding (hemorrhage) that... |
|
2023-2031 Report on Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Player, Region, Type, Application and Sales Channel
This report studies the ICAD (Intracranial Atherosclerotic Disease) Pathology market, covering market size for segment by type (ICAD Stent, PTA Balloon, etc.), by application (Hospitals, Clinics, etc.), by sales channel (Direct Channel, Distribution ... |
|
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth 2023-2029
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of... |
|
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Insights: Impact of COVID-19 and Future Expectations to 2028
Intracranial atherosclerotic disease (ICAD) is the most common cause of stroke worldwide. It is the progressive narrowing of the cerebral arteries within the skull (intracranial). Strokes may be caused either by clots or by bleeding (hemorrhage) that... |
|
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Research Report 2023
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market with multiple angle... |
|
Global ICAD (Intracranial Atherosclerotic Disease Pathology) Market Insights: Impact of COVID-19 and Future Expectations to 2028
The ICAD (Intracranial Atherosclerotic Disease Pathology) market revenue was 185.41 Million USD in 2022, and will reach 343.21 Million USD in 2028, with a CAGR of 10.81% during 2022-2028. This report elaborates the market size, market ... |
|
ICAD (Intracranial Atherosclerotic Disease) Pathology Market, Global Outlook and Forecast 2023-2029
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of... |
|
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Insights, Forecast to 2029
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of... |
|
Global ICAD (Intracranial Atherosclerotic Disease Pathology) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Market Overview of Global ICAD (Intracranial Atherosclerotic Disease Pathology) market: According to our latest research, the global ICAD (Intracranial Atherosclerotic Disease Pathology) market looks promising in the next 5 years. As of 2022, t... |
|
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook 2022
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme... |
